{
    "medicine_id": "331140f9f7847739315ff47a0c6522dcf4fdb75e",
    "platform_id": "DB05235",
    "metadata": {
        "name": "Eucrisa 20 mg 1g Ointment",
        "composition": "20 mg 1g NRP409",
        "clinical_particulars": {
            "therapeutic_indications": "For use in treatment of hypothyroidism",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The company is hoping that NRP409 will mark a significant improvement in thyroid HRT by reducing the variability of the more active hormone s availability while reducing the safety risk associated with other T3 based therapies",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}